Combination immunotherapy with soluble tumor necrosis factor receptors plus interleukin 1 receptor antagonist decreases sepsis mortality

Journal article

Peer reviewed

Daniel G REMICK, Douglas R CALL, Samuel J EBONG, David E NEWCOMB, Pia NYBOM, Jean A NEMZEK and Gerald E BOLGOS

Critical care medicine, Vol.29(3), pp.473-481

2001

Handle:

https://hdl.handle.net/2376/114329

PMID: 11373406

Abstract

Biological and medical sciences

Medical sciences

Immunomodulators

Pharmacology. Drug treatments

11 Record Views

Title: Combination immunotherapy with soluble tumor necrosis factor receptors plus interleukin 1 receptor antagonist decreases sepsis mortality
Creators: Daniel G REMICK - Department of Pathology, University of Michigan, Ann Arbor, MI, United States
Douglas R CALL - Department of Pathology, University of Michigan, Ann Arbor, MI, United States
Samuel J EBONG - Department of Pathology, University of Michigan, Ann Arbor, MI, United States
David E NEWCOMB - Department of Pathology, University of Michigan, Ann Arbor, MI, United States
Pia NYBOM - Department of Pathology, University of Michigan, Ann Arbor, MI, United States
Jean A NEMZEK - Department of Pathology, University of Michigan, Ann Arbor, MI, United States
Gerald E BOLGOS - Department of Pathology, University of Michigan, Ann Arbor, MI, United States
Publication Details: Critical care medicine, Vol.29(3), pp.473-481
Publisher: Lippincott; Hagerstown, MD
Identifiers: 99900548325301842
Language: English
Resource Type: Journal article